Michael Greenebaum Appointed Chair of University of Maryland School of Medicine's Board of Visitors

Leadership Transition at UMSOM

On December 9, 2024, the University of Maryland School of Medicine (UMSOM) announced the appointment of Michael Greenebaum as the new Chair of its Board of Visitors. This significant transition in leadership follows his tenure as the inaugural Vice Chair since 2021 and being a dedicated board member since 2012.

Dean Mark T. Gladwin, M.D., shared his excitement about Mr. Greenebaum's appointment, highlighting the profound impact he has already made within the institution. Greenebaum expressed his deep-rooted connection to UMSOM, recounting personal experiences, including his mother’s treatment at the Maryland Comprehensive Cancer Center and his own journey as a patient. He stated, “I feel so passionate about the goals of this institution, and my real goal is to draw on the strengths and talent of our diverse Board, where we can work together to achieve the greater good.”

A Legacy of Philanthropy and Commitment

Michael Greenebaum, also known for his philanthropic efforts, has a personal stake in the institution's success. His family’s generous contributions include the founding gift for the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center back in 1994. This well-established philanthropy has supported countless lives and advances in medical care.

During his time as Vice Chair, Greenebaum was instrumental in launching crucial initiatives, including the formation of the UMSOM philanthropy team, which aligned the development efforts of both the School of Medicine and the Medical Center. His leadership in the Board's Campaign Committee also led to an impressive fundraising achievement of $6.4 million within a mere two years. He has further demonstrated his commitment as a member of the Innovation Committee, helping to create a philanthropic fund dedicated to supporting emerging technologies.

Vision for Future Growth

With his appointment as Chair, Greenebaum brings a vision for continuing the institution’s legacy of excellence. “I can think of no better leader and dedicated individual to take the helm than Michael Greenebaum,” said Dean Gladwin. Greenebaum’s extensive experience in healthcare and community service, underscored by his role as President of Greenebaum Enterprises, a prominent real estate development firm, positions him uniquely to lead UMSOM into its future.

His strategic leadership has positively influenced Maryland's economic landscape, aligning with his ongoing efforts to enhance healthcare services. As a board member at the UM Marlene and Stewart Greenebaum Comprehensive Cancer Center and the founder of the Maryland Half Marathon, which has raised over $8 million for cancer research, Greenebaum embodies a profound commitment to community health.

Continuing the Mission

Greenebaum’s dedication extends beyond the immediate institution. As a Trustee of The Greenebaum Family Foundation, he focuses on enhancing the human condition through education and medicine, showcasing a strong intent to further UMSOM's mission in transforming healthcare.

He succeeds Cynthia Egan, who has served with distinction since 2013, including the last four years as Chair, and has now been honored with the title of Chair Emerita.

An Institution of Excellence

Founded in 1807, the University of Maryland School of Medicine has built a rich history as the first public medical school in the United States. Today, it boasts a powerful research enterprise, ranking high in both national research productivity and support. Serving nearly 2 million patients annually with an operating budget exceeding $1.2 billion, the School exemplifies a commitment to medical excellence. Mr. Greenebaum’s leadership is poised to enhance this legacy further as he navigates the future with a focus on innovation and collaboration, ensuring continued growth and success for UMSOM.

For more information on UMSOM, visit medschool.umaryland.edu.